Feasibility Clinical trial of endovascular Electroencephalogram Measurement Device - eEEG feasibility trial

Matsumaru Yuji0 个研究点目标入组 5 人开始时间: 2022年12月26日最近更新: 2024年4月1日

试验速览

暂无简介。

•1) Intractable epilepsy patients
•2) Patients for whom the WADA test is performed
•3) Patients with the vascular anatomy that allows catheter placement into either the cavernous sinus, transverse sinus, or superior sagittal sinus
•4) Patients between the ages of 18 and 70 (at the time of obtaining consent)

•1) Patients with intellectual disability of moderate level or higher (*1)
•2) Patients with occlusion or thrombus in the common carotid artery or internal jugular vein
•3) Patients who are receiving antithrombotic therapy
•4) Patients with a predisposition to bleeding or coagulation abnormalities (*2)
•5) Patients allergic to contrast media
•6) Patients with metal allergies
•7) Patients who are pregnant or of childbearing potential
•8) Patients who are judged by the investigator to be inappropriate to participate in this study.
•*1: The criteria for intellectual disability are as follows
•Mild: able to work
•Moderate: Able to answer questions but unable to work
•Severe: Unable to speak
•*2: Criteria for predisposition to bleeding and coagulation abnormalities are as follows
•Platelet count: less than 100,000/micro L
•APTT: 39 seconds or longer
•PT-INR: 1.1 or higher

发起方

Matsumaru Yuji